(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -71.19%-1.22M | -711.48K |
Payments to suppliers for goods and services | -71.19%-1.22M | ---711.48K |
Direct interest received | 5,674.16%75.53K | --1.31K |
Operating cash flow | -60.87%-1.14M | ---710.18K |
Investing cash flow | ||
Cash flow from continuing investing activities | -80.81%-591.05K | -326.89K |
Capital expenditure reported | -86.69%-581.28K | ---311.36K |
Net PPE purchase and sale | 37.09%-9.77K | ---15.53K |
Cash from discontinued investing activities | ||
Investing cash flow | -80.81%-591.05K | ---326.89K |
Financing cash flow | ||
Cash flow from continuing financing activities | 5.17M | |
Net common stock issuance | ---- | --5.17M |
Cash from discontinued financing activities | ||
Financing cash flow | ---- | --5.17M |
Net cash flow | ||
Beginning cash position | 529.52%4.91M | --780.45K |
Current changes in cash | -141.95%-1.73M | --4.13M |
End cash Position | -35.28%3.18M | --4.91M |
Free cash from | -67.15%-1.73M | ---1.04M |
Accounting Standards | US-GAAP | US-GAAP |
No Data